Principal protected notes

Product performance

The three products reviewed this month all have a strike date of 11 December 2009. The products are valued weekly and the results are shown along with the performance of the underlying asset. All three products are fairly typical of products that are…

Balancing correlation

Credit Suisse is offering US investors a 5.5-year structured product that is based on a basket that is balanced by the inclusion of the iShares Barclays Tips Bond Fund ETF. As well as proving to have low volatility, the fund is not correlated to the…

Product performance

Based on the FTSE 100, this month FVC compares the virtues of three products structures common to the UK market that link to the FTSE 100

Product performance

Comparing the performance of principal-protected, accelerated growth and reverse convertible products, and analysing the pricing of the Dunbar Bank Zurich Triple Account

Volatility capped access to funds

ING Bank is offering Swedish investors a product that has the classic benefits of allowing access to an unusual and potentially risky underlying while changing its return profile. The product is based on the East Capital Russia Fund, giving local…

Counting the cost of counterparty risk

A few years ago no-one worried about counterparty credit risk. Then a year ago that was all anyone cared about. As markets begin to settle down, the shake-up could have longer-term implications for the structured products market. By John Ferry

Retrospective: A simple plan

Barclays Bank issued a straightforward minimum return product just before the financial crisis, linked to the performance of the FTSE 100 index. Ensuing volatility and widening CDS spreads show why such products are rare in today’s markets

Interest rates call

HSBC is offering US investors a 10-year investment in interest rates that pays 7% in year one and potentially as much in following years. The product is wrapped in a certificate of deposit, but investors may lose out if HSBC exercises its call at five…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here